Page 76 - JCTR-11-3
P. 76

Journal of Clinical and
            Translational Research                                              N-NOSE: Early cervical cancer screening



            44.  Miles A, McClements PL, Steele RJ, Redeker C, Sevdalis N,   information regarding test indication.  Am J Epidemiol.
               Wardle J. The psychological impact of a colorectal cancer   2019;188(4):703-708.
               diagnosis following a negative fecal occult blood test result.      doi: 10.1093/aje/kwy274
               Cancer Epidemiol Biomarkers Prev. 2015;24(7):1032-1038.
                                                               49.  Zauber AG. The Impact of screening on colorectal cancer
               doi: 10.1158/1055-9965.EPI-15-0004                 mortality and incidence: Has it really made a difference? Dig
            45.  Shao SH, Allen B, Clement J,  et al. Multi-cancer early   Dis Sci. 2015;60:681-691.
               detection  test  sensitivity  for  cancers  with  and  without      doi: 10.1007/s10620-015-3600-5
               current population-level screening options.  Tumori.
               2023;109(3):335-341.                            50.  Loud JT, Murphy J. Cancer Screening and Early Detection in
                                                                  the 21  Century. Netherlands: Elsevier; 2017. p. 121-128.
                                                                       st
               doi: 10.1177/03008916221133136
                                                               51.  Dai JY, Georg Luebeck E, Chang ET, et al. Strong association
            46.  Fenton JJ, Barton MB, Geiger AM, et al. Screening clinical   between reduction of late-stage cancers and reduction of
               breast examination: How often does it miss lethal breast   cancer-specific mortality in meta-regression of randomized
               cancer? J Natl Cancer Inst Monogr. 2005;2005(35):67-71.  screening trials across multiple cancer types. J Med Screen.
               doi: 10.1093/jncimonographs/lgi040                 2024;31:211-222.
            47.  Imperiale  TF.  Quantitative  immunochemical  fecal  occult      doi: 10.1177/09691413241256744
               blood tests: Is it time to go back to the future? Ann Intern   52.  Curry SJ, Byers T, Hewitt M. Potential of screening to reduce
               Med. 2007;146(4):309-311.                          the burden of cancer. In: Fulfilling the Potential of Cancer
               doi: 10.7326/0003-4819-146-4-200702200-00013       Prevention and Early Detection.  United  States:  National
                                                                  Academies Press; 2003.
            48.  Doria-Rose VP, Kamineni A, Barrett MJ, Ko CW, Weiss NS.
               Case-control studies of the efficacy of screening tests that   53.  Perkins R, Mitchell E. Cervical cancer disparities. J Natl Med
               seek to prevent cancer incidence: Results of an approach   Assoc. 2023;115(2):S19-S25.
               that utilizes administrative claims data that do not provide      doi: 10.1016/j.jnma.2023.02.006













































            Volume 11 Issue 3 (2025)                        70                            doi: 10.36922/jctr.24.00080
   71   72   73   74   75   76   77   78   79   80   81